There is not yet a drug for everything, but there is one now for "hypotrichosis of the eyelashes," a fancy way of describing the condition in which you have too few or inadequate eyelashes.

Allergan, the Irvine-based pharmaceutical company better known for making Botox, has received FDA approval to begin selling its prescription drug Latisse to the eyelash-impaired.

Latisse is already sold under the name Lumigan to treat glaucoma, an eye disease. Allergan scientists no ...

( Back to Article )